About Event
Industry’s Definitive Meeting for Cross-Functional Collaboration Across ROAs, Modalities & CNS Indications
What's new for 2024?
Join your peers to:
Stay up to date with the latest translational advancements in blood-brain barrier delivery, as well as insights from Roche’s Brainshuttle entering phase 1
Explore engineering and hardware innovation in device-mediated delivery systems, strategizing how to enhance their clinical scalability
Explore beyond transferrin for new receptor-ligand pair opportunities, brainstorming strategies to enhance BBB penetration
Uncover cutting-edge technologies, such as radiolabelling, to measure and quantify CNS biodistribution
Collaboratively tackle challenges surrounding safety, off-target toxicity, translatability, and formulation to optimize brain delivery of small molecules, biologics, AAVs and more
Who Will You Meet?
This forum will unite preclinical, translational, and early clinical drug delivery experts working on neurodegeneration, neuropsychiatry, glioblastoma, neuroimmunology, and many other indications. Join 100+ neuroscientists, neurobiologists, PKPD experts, medicinal chemists, protein engineers, biochemists, and device experts across the rapidly expanding CNS industry.
What Your Peers Have To Say:
“The CNS Drug Delivery Summit is an excellent opportunity to learn how peers in academia and industry are developing medical technologies to achieve broader therapeutic windows to unleash the full potential of novel therapies designed to address unmet needs in neuroscience and neuro-oncology.”
“Overcoming the challenges of enhanced CNS access for drug delivery requires staying at the forefront of research. I look forward to the exchange of ideas and innovative solutions from leaders within the field.”
“Overcoming the challenges of enhanced CNS access for drug delivery requires staying at the forefront of research. I look forward to the exchange of ideas and innovative solutions from leaders within the field.”
“Small conference with focused group of experts, gives good networking opportunities. One talk at a time. Good combination of modalities and interesting insertion of devices.”
